2025-01-082025-01-08https://203.71.86.71/handle/123456789/119簡介： 細胞治療與再生醫學國際博士學位學程(IPCTRM)此學程目的在促進轉譯醫學與臨床試驗於細胞/幹細胞治療之發展。IPCTRM研究涵蓋諸多領域，包含癌症治療中的免疫細胞應用；再生過程之血液與間質幹細胞；傷口癒合；移植物對抗宿主疾病；肌萎縮性脊髓側索硬化症；癌症幹細胞及特殊疾病之誘導性多功能幹細胞作為藥物篩選平台。IPCTRM將細胞領域之專家與科學家彙集一堂，不僅加速產出優異之基礎研究，也著重於臨床轉譯醫學研究，及產業化的細胞/幹細胞產品研發。 發展重點：  癌症免疫治療  多功能微小血液幹細胞  間質幹細胞  胚胎生殖細胞與誘導性多功能幹細胞(iPS細胞)  疾病iPS細胞作為藥物篩選平台  FDA/TFDA細胞治療法規  CMC/藥物毒性/臨床試驗/IRB訓練 教育目標：培育細胞治療與再生醫學基礎與臨床醫學整合能力之人才 核心能力：  具備細胞治療與再生醫學基礎與臨床醫學整合能力  具有洞悉細胞治療與再生醫學研究國際趨勢之能力  具有前瞻性細胞治療與再生醫學之研究設計與法規管理能力  具有細胞治療與再生醫學相關議題之專業研究能力  正確學術倫理與醫學研究精神To address the medical needs of ageing populations worldwide, medical researchers are exploring new methods of treating diseases through cell therapy and regeneration medicine. At the forefront of this trend, the pioneering faculty at TMU established Taiwan’s first research program that specializes in cell therapy research and regeneration medicine. They also set up Taiwan’s first university-based Good Tissue Practice (GTP) laboratory. The mission of IPCTRM is twofold: to provide students with the necessary training to become leading medical researchers and to promote translational medicine through cell-based therapy clinical trials. At the GTP lab, students learn how to produce cell-based medical products, gaining the knowledge and skills required for careers in the rapidly expanding field of cell therapy and regeneration medicine. Our curriculum focuses on various fields in Regenerative Medicine, namely Ø Basic Research Skills：Stem Cell Research, Cell Biology, Molecular Biology, Immune Cell Therapy Ø Translational Application：Clinical Study, Medical Statistics, Special Topics in Cell Therapy & Regeneration Medicine Ø Industrial Application & Regulation Affairs：Research ethics, Forum in cell therapy & regeneration medicine, Medical industry and cell therapy regulations and patentsAcademic Institute